James F. Polewaczyk, Executive Vice President at IDEXX LABORATORIES INC /DE (IDXX), sold 20,000 shares at $558.89 ($11.2M) on 2021-05-28, disclosed to the SEC on 2021-06-01.
Open-market sale of $11.2M IDXX by Executive Vice President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $558.89 | 1,039 | $581K | 5.2% |
| 2 | $558.89 | 1,039 | $581K | 5.2% |
| 3 | $559.77 | 1,370 | $767K | 6.8% |
| 4 | $559.77 | 1,370 | $767K | 6.8% |
| 5 | $560.79 | 1,274 | $714K | 6.4% |
| 6 | $560.79 | 1,274 |
| $714K |
| 6.4% |
| 7 | $561.77 | 1,429 | $803K | 7.1% |
| 8 | $561.77 | 1,429 | $803K | 7.1% |
| 9 | $562.65 | 2,462 | $1.4M | 12.3% |
| 10 | $562.65 | 2,462 | $1.4M | 12.3% |
| 11 | $564.04 | 1,713 | $966K | 8.6% |
| 12 | $564.04 | 1,713 | $966K | 8.6% |
| 13 | $564.73 | 513 | $290K | 2.6% |
| 14 | $564.73 | 513 | $290K | 2.6% |
| 15 | $565.56 | 200 | $113K | 1.0% |
| 16 | $565.56 | 200 | $113K | 1.0% |
| Total | $561.91 avg | 20,000 | $11.2M | 100% |
| Filing → |
| IDXX | SELL | 2023-08-31 | $23.1M | — | Filing → |
| IDXX | SELL | 2021-12-01 | $2.9M | — | Filing → |
| IDXX | SELL | 2020-05-12 | $9.7M | — | Filing → |